Synthesis of Cis-Diammine (1,1-cyclobutane dicarboxylate) Platinum(II)
(ندگان)پدیدآور
Nemati kharat, AliTamaddoni Jahromi, BaharehMohammadifar, EhsanZareyi, Jalehنوع مدرک
TextResearch Note
زبان مدرک
Englishچکیده
Platinum-based anticancer drugs are chemotherapeutic agents to treat cancer. Carboplatin (cis diammine cyclobutane dicarboxylate platinum (II)) is a second generation drug that has less toxic than cisplatin, allowing for high dosages. In the first stage, 1,3-Cyclobutane dicarboxylic acid, a key intermediate for the preparation of carboplatin, have been synthesized in good yields using different methodology to achieve high purity then carboplatin was synthesized from the reaction of the prepared ligand with cisplatin. Purity of prepared carboplatin was confirmed by High-Performance Liquid Chromatography (HPLC). Platinum(II) complex carboplatin,have been characterized with 1H and 13C nuclear magnetic resonance spectra and infrared spectroscopy.
کلید واژگان
1,3- cyclobutane dicarboxylic acidPlatinum complexes
Carboplatin
Anticancer
Organic Chemistry
شماره نشریه
4تاریخ نشر
2017-08-011396-05-10
ناشر
Iranian Institute of Research and Development in Chemical Industries (IRDCI)-ACECRسازمان پدید آورنده
School of Chemistry, University College of Science, University of Tehran, Tehran, I.R. IRANSchool of Chemistry, University College of Science, University of Tehran, Tehran, I.R. IRAN
School of Chemistry, University College of Science, University of Tehran, Tehran, I.R. IRAN
School of Chemistry, University College of Science, University of Tehran, Tehran, I.R. IRAN




